StimOxyGen
stimoxygen.com
Science & Engineering
Biotechnology
Health Care
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Jan 2025 · 21 mo ago
Team
1-10
employees, estimated range
Grants
$1.3M
3 grants · CORDIS
Backers
1
Clarendon Fund Managers
The money's age
Due for its next round
21 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 16, 2025
Raised a round Venture round
Jan 1, 2025
Won a grant $771k · CORDIS
Apr 1, 2024
Won a grant $194k · CORDIS
Dec 7, 2021
Raised a round Venture round
Dec 1, 2021
Won a grant $380k · CORDIS
Mar 9, 2021
Founded per the company register
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jan 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Jan 2025 | $771k | — | CORDIS |
| Grant | Apr 2024 | $194k | — | CORDIS |
| Venture round | Dec 2021 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Dec 2021 | $380k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | STIMOXYGEN LTD | Companies House |
| Registered | 9 Mar 2021 |
Backed byfrom the funds' portfolios and accelerator catalogs
Clarendon Fund Managers Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Entia is making life better for people receiving cancer treatment.
Gamgee is developing personalised mRNA vaccines as a cancer treatment for dogs, built from each dog’s tumour. See how it works with vets…
Persevere Therapeutics novel drug is focused on improving effectiveness of cancer treatments.
Stratosvir. Revolutionizing cancer treatment through viral immunotherapy.
KAHR Bio: Pioneering Immunotherapeutics for Advanced Cancer Treatment.
NuclearMediX develops radiopharmaceuticals for cancer diagnosis and treatment. FETO has completed Phase 2 in neuroendocrine tumours.
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Belfast
United Kingdom
HQ
Derry
United Kingdom
Regional office
School of Pharmacy and Pharmaceutical Sciences Cromore Road Coleraine Co. Derry/Londonderry BT52 1SA